<DOC>
	<DOCNO>NCT00446043</DOCNO>
	<brief_summary>This multi-centre , open-label , non-comparative study evaluate long-term safety efficacy profile Adapalene/Benzoyl Peroxide Gel . Subjects evaluate Baseline , Weeks 1 2 , Months 1 , 2 , 4 , 6 , 8 , 10 , 12 . Safety evaluate spontaneous report Adverse Events ( AEs ) , Local Tolerability Assessment ( Erythema , Scaling , Dryness , Stinging/Burning ) , routine laboratory testing ( haematology , blood chemistry , urinalysis ) , monitor suspected sensitization . Efficacy evaluate analysis Percent Change Baseline Inflammatory , Noninflammatory , Total Lesion Counts , Subject â€™ Assessment Acne .</brief_summary>
	<brief_title>A Long-Term Study Demonstrate Efficacy Safety Adapalene/Benzoyl Peroxide Topical Gel Subjects With Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>A clinical diagnosis acne vulgaris facial involvement A minimum 20 50 Inflammatory lesion A minimum 30 100 Noninflammatory lesion Subjects presence nodule cyst . Acne conglobata , acne fulminans , secondary acne , severe acne . Underlying disease require use interfering topical systemic therapy . Use prohibit medication prior study unless appropriate washout period document</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Adapalene</keyword>
	<keyword>Benzoyl Peroxide</keyword>
</DOC>